The new report released last week aims to provide guidance to the manufacturers and importers of vaccines in the country so as to strengthen their AE/AEFI (adverse events following immunisation) monitoring and reporting and pharmacovigilance department to ensure patient safety.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RQ5dJZD
via IFTTT
No comments:
Post a Comment